Navigation Links
Essilor Cancels Four Million Shares
Date:7/13/2010

CHARENTON-LE-PONT, France, July 13, 2010 /PRNewswire-FirstCall/ -- On June 28, 2010, Essilor cancelled 4,000,000 shares, in line with its commitment not to create any dilution for existing shareholders. The two-part transaction was carried out as follows:

    - 2,130,000 shares were cancelled to offset the dilutive impact of the
      vesting of performance shares or the exercise of stock options granted
      to employees.

    - 1,870,000 shares were cancelled to offset the dilution resulting from
      the conversion of the now mature OCEANE convertible bonds. The shares
      had been purchased as part of a program launched in 2008 to buy back up
      to 6,900,000 shares for allocation on conversion of the OCEANE bonds
      then outstanding. To date, Essilor has bought back 5,200,000 shares
      under this program, of which 3,370,000 have now been cancelled.

The world leader in ophthalmic optical products, Essilor International researches, develops, manufactures and markets around the world a wide range of lenses to improve and protect eyesight. Its flagship brands are Varilux(R), Crizal(R), Essilor(R), Definity(R) and Xperio(TM).

Based in France, the company reported consolidated revenue of more than EUR3.2 billion in 2009, with 34,700 employees and operations in 100 countries.

For more information, please visit http://www.essilor.com.

The Essilor share trades on the NYSE Euronext Paris market and is included in the CAC 40 index.

    Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.

    Investor Relations and Financial Communications
    Veronique Gillet - Sebastien Leroy
    Phone: +33(0)1-49-77-42-16
    http://www.essilor.com



'/>"/>
SOURCE Essilor
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Essilor - 2010 First Quarter Report
2. Essilor Acquires FGX International, Becoming a Major Player in a New Fast-Growing Market
3. iPierian Closes $22 Million Series B Financing Led By Google Ventures
4. China-Biotics, Inc. Announces US$20 million Share Buyback Program
5. Bionovo Announces a $15 Million At-The-Market Firm Commitment Financing Agreement
6. DURECT Corporation Secures $50 Million Committed Equity Financing Facility
7. Bacterin International Holdings, Inc. Completes Merger and $7.5 Million Raise
8. Vermillion Announces Issuance of Patent for Alzheimers Disease Diagnosis
9. Patient Safety Technologies Completes $6.0 Million Equity Financing
10. Hanger Orthopedic Group, Inc. Announces Three Acquisitions With Annual Revenues of $14.0 Million
11. Baxano, Inc. Announces Close of $30 Million Series C Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , Dec. 6, 2016 Radioisotopes are radioactive ... are produced either by using nuclear research reactor or ... form of alpha, beta or gamma when changed to ... used in Nuclear medicine, specifically in medical diagnostics. In ... information about a human body,s functioning. Radiotherapy is also ...
(Date:12/6/2016)... Human Vaccines Market: Scope and Methodology ... country wise analysis of the human vaccines market. ... vaccines products, raw material suppliers, vaccine processing companies, ... The report provides qualitative and quantitative analysis ... comprises market dynamics, trends, product overview, and country-level ...
(Date:12/6/2016)... 2016 Two new disaster drones delivered telemedical ... mass casualty event Tuesday at John Bell Airport in ... before an audience including Mississippi ... Security, Federal Law Enforcement Agencies, and the United Nations. ... (Health Integrated Rescue Operations), was developed by Italo ...
Breaking Medicine Technology:
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Sharon Kleyne, ... Global Climate Change and Your Health on Voice of America, declared on her radio ... call attention to the fact that when these bullies attack leaders in corporate America, ...
(Date:12/7/2016)... ... 07, 2016 , ... Delete® - Tattoo Removal and Laser Salon Offers Delightful ... Save Up To 33% Off Botox® and Juvederm® Products Now Through December 31, 2016 ... Delightful Deals on Botox® and Juvederm® just in time for the holiday ...
(Date:12/7/2016)... , ... December 07, 2016 , ... The medical profession ... and winter seasons. One major study analyzing heart attacks among 138,602 people recorded ... of a given year. We would all agree of course–no time of year is ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... WellnessPro Plus for consumers and healthcare professionals to manage chronic and acute ... the treatment modalities available in a single device. The announcement is part ...
(Date:12/7/2016)... ... ... “Tomorrow Trump Goes To Washington”: a brief but engaging illustration depicting the ... “Tomorrow Trump Goes To Washington” is the creation of published author, Nancy Engestrom, a ... Nancy attributes her patriotic nature to her WWII veteran father. She says, “I ...
Breaking Medicine News(10 mins):